Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combination of CAR‑T cell therapy and radiotherapy: Opportunities and challenges in solid tumors (Review). | Oncol Lett | 2023 | 37274466 | PubTator, text mining | PubMed |
| Development of Optical-Based Molecularly Imprinted Nanosensors for Adenosine Detection. | ACS Omega | 2023 | 37273602 | PubTator, text mining | PubMed |
| Epigenetic regulation and therapeutic targets in the tumor microenvironment. | Mol Biomed | 2023 | 37273004 | PubTator, text mining | PubMed |
| Cellular activation pathways and interaction networks in vascularized composite allotransplantation. | Front Immunol | 2023 | 37266446 | PubTator, text mining | PubMed |
| Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future. | Pharmaceuticals (Basel) | 2023 | 37259416 | PubTator, text mining | PubMed |
| Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV. | Pharmaceuticals (Basel) | 2023 | 37259406 | PubTator, text mining | PubMed |
| Phenotypic and Genotypic Characterization of Antimicrobial Resistance in Streptococci Isolated from Human and Animal Clinical Specimens. | Curr Microbiol | 2023 | 37256427 | PubTator, text mining | PubMed |
| Single-cell sequencing technology in colorectal cancer: a new technology to disclose the tumor heterogeneity and target precise treatment. | Front Immunol | 2023 | 37256123 | PubTator, text mining | PubMed |
| The role of dendritic cells and their immunometabolism in rheumatoid arthritis. | Front Immunol | 2023 | 37251399 | PubTator, text mining | PubMed |
| The chemokine landscape: one system multiple shades. | Front Immunol | 2023 | 37251376 | PubTator, text mining | PubMed |
| A senescence-associated signature refines the classification of different modification patterns and characterization of tumor immune microenvironment infiltration in triple-negative breast cancer. | Front Pharmacol | 2023 | 37251343 | PubTator, text mining | PubMed |
| Prognostic Value and Immunological Role of P4HA3 in Colon Adenocarcinoma. | Int J Gen Med | 2023 | 37251280 | PubTator, text mining | PubMed |
| Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma. | Cancer Res | 2023 | 37249584 | PubTator, text mining | PubMed |
| Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines. | J Autoimmun | 2023 | 37245259 | PubTator, text mining | PubMed |
| ESKAPE and Beyond: The Burden of Coinfections in the COVID-19 Pandemic. | Pathogens | 2023 | 37242413 | PubTator, text mining | PubMed |
| Neuroendocrine Influencers and Associated Factors That Shape Jaw Movement and Growth in Temporomandibular Joint Disorder Management: A Systematic Review of Clinical and Radiographic Evidence. | J Pers Med | 2023 | 37241010 | PubTator, text mining | PubMed |
| Gene Expression Profiling of Fibroepithelial Lesions of the Breast. | Int J Mol Sci | 2023 | 37240386 | PubTator, text mining | PubMed |
| GNAQ-Regulated ZO-1 and ZO-2 Act as Tumor Suppressors by Modulating EMT Potential and Tumor-Repressive Microenvironment in Lung Cancer. | Int J Mol Sci | 2023 | 37240145 | PubTator, text mining | PubMed |
| Pediatric Gaucher Disease Presenting with Massive Splenomegaly and Hepatic Gaucheroma. | Children (Basel) | 2023 | 37238417 | PubTator, text mining | PubMed |
| CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies. | Diagnostics (Basel) | 2023 | 37238199 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=33